Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Youdao to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 20
-
NetEase to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 20
-
U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics' Proprietary Radiopharmaceutical Cancer Therapy
-
Festi hf.: Presentation of Q4 and 12M 2024 results
-
From AI Templates to Actionable Analytics: Sinch Mailjet Empowers Marketers for Success in 2025
-
The UNH Interoperability Lab Receives TISAX® Label to Further Support Automotive Testing
-
Wyss Center Partners with BrainScape Medical to License Groundbreaking Epios® Technology
-
Advantest Opens Registration for International VOICE 2025 Developer Conference, May 12-14
-
Kao Recognized as Global Environmental Leader with a CDP Triple ‘A’ for Fifth Consecutive Year
-
Tax Systems Launches Alphatax in the UAE to Streamline Corporate Tax Compliance
-
Verne Expands Helsinki Data Center Campus With Strategic Site Acquisition
-
Sharaf DG Boosts Returns on Ad Spends and Goes Green with Gupshup Conversation Cloud
-
Oracle AI Agents Help HR Leaders Reshape the Employee Experience
-
POLYTECH Health & Aesthetics Strengthens Its Presence in the Nordics
-
Windward Launches Critical Maritime Infrastructure Protection, an AI Solution to Detect and Counter Threats to the World's Essential Infrastructure
-
ION's Openlink V25: Advancing treasury and commodity management
-
Rotana TV Appoints SPEX as Exclusive Advertising Partner for TV and Digital Advertising
-
S.PELLEGRINO YOUNG CHEF ACADEMY: THE COUNTDOWN BEGINS TO CROWN THE WORLD'S BEST YOUNG CHEF UNDER 30
-
Atombit launches its journey of radical transformation for CX and EX with Amplify Analytix acquisition
-
Unleashing Your Inner Artist: Fire Mountain Gems & Beads Empowers Creativity Across the Globe on a New Segment by Empowered with Meg Ryan
-
OP Mortgage Bank: Financial Statements Bulletin for 1 January‒31 December 2024
-
Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC
-
Net Asset Value
-
VGP Announces Webcast to Review FY 2024 Financial Results
-
Actimed Therapeutics Expands Intellectual Property Portfolio
-
QualityStar Wins 2024 Global Recognition Award for Excellence in Promoting Natural Wellness Solutions
-
Emaar Hospitality Group Opens Vida Dubai Mall in the Heart of Downtown
-
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
-
FXellence Launches Multimarket Cross-Border Payment Solution Powered by Currencycloud
-
Konsolidator’s Annual Report 2024 - From Growth to Resilient Growth
-
Kering: Gucci ends its collaboration with Sabato de Sarno
-
Danish Government Borrowing and Debt 2024
-
Capgemini and Peugeot Sport renew their partnership to tackle technological and sustainable challenges in sports performance
-
Securitas AB Full Year Report 2024 | January-December
-
KT&G Successfully Improves Profitability in First Year of New Leadership, Promises Active Shareholder Returns
-
Coop Pank AS will hold an investor webinar to introduce the results for the fourth quarter and 12 month of 2024
-
Major Shareholder announcement
-
Boliden: Mineral Resources and Mineral Reserves 2024
-
Sonim Spot(TM) H100 Mobile Hotspot Now Available in Europe, Launching with Telia in Finland
-
Pernod Ricard: Determined to Navigate Current Cyclical Headwinds With Resilience and Agility
-
FINANCIAL STATEMENTS BULLETIN for 1 January–31 December 2024 Significant profitability improvement in a weak demand environment
-
Pulsar Helium Announces Appointment of Hovde Group as Co-placement Agent for Second Tranche of Private Placement
-
ACI Worldwide Extends Fintech Partnership Ecosystem to Fight APP Fraud in Europe and the UK
-
Bringing True Japanese Eyewear to World: "JINS Abbot Kinney Store" in Los Angeles, U.S., Marks Debut of New Customer Experience for Accelerated JINS Global Expansion
-
Solar A/S: No. 2 2025 Annual report 2024
-
Annual Report 2024
-
OP Corporate Bank plc's Financial Statements Bulletin 1 January–31 December 2024
-
OP Financial Group's Financial Statements Bulletin 1 January–31 December 2024: Excellent business performance continued – full-year operating profit EUR 2,486 million
-
NB Private Equity Partners Announces Transaction in Own Shares
-
Launch of new share buyback programme in accordance with the ‘Safe Harbour’ rules

